# The Feasibility of Dexmedetomidine for Awake Fiberoptic Nasal Intubation

> **NCT00815893** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Kaohsiung Medical University Chung-Ho Memorial Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Awake Fiberoptic Nasal Intubation

## Interventions

- **DRUG:** dexmedetomidine
- **DRUG:** Normal Saline 0.9%
- **DRUG:** propofol 1%

## Key facts

- **NCT ID:** NCT00815893
- **Lead sponsor:** Kaohsiung Medical University Chung-Ho Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-08
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2009-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00815893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00815893, "The Feasibility of Dexmedetomidine for Awake Fiberoptic Nasal Intubation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00815893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*